SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Palantir Technologies, Inc. engages in the business of building and deploying software platforms that serve as the central operating systems for its customers. It operates through the Commercial and Government segments. The Commercial segment focuses on customers working in non-government industries. The Government segment is involved in providing services to customers that are the United States government and non-United States government agencies. Its platforms are widely used in areas such as defense, intelligence, healthcare, energy, and financial services, supporting data integration, large-scale analytics, and operational decision-making. The company was founded by Alexander Ceadmon Karp, Peter Andreas Thiel, Stephen Cohen, Joseph Lonsdale, and Nathan Dale Gettings in 2003 and is headquartered in Aventura, FL.

Palantir Technologies Inc - Ordinary Shares - Class A

Palantir Technologies Inc

Palantir Technologies is trending following a massive quarterly earnings beat and raised full-year guidance that triggered a significant after-hours rally. The community is actively debating the company's aggressive growth trajectory and AI sovereignty narrative while mocking skeptics and short-sellers who were caught off guard by the company's strong execution.

GameStop Corp. engages in offering games and entertainment products through its ecommerce properties and stores. The firm’s stores and ecommerce sites operate primarily under the names GameStop, EB Games, and Micromania. It operates through the following geographical segments: United States, Canada, Australia, and Europe. The company was founded by Daniel A. DeMatteo in 1996 and is headquartered in Grapevine, TX.

Gamestop Corporation - Ordinary Shares - Class A

GameStop Corp

GameStop is trending due to the company's decision to exchange 1.4 billion dollars of convertible debt for new common shares, sparking an intense debate between bulls who view the debt reduction as a strategic move and bears who interpret it as a dilutive blow to existing shareholders. The community remains deeply polarized, with many retail investors actively discussing whether this move signals a broader corporate acquisition plan or further exploitation of long-term shareholders.

Replimune Group, Inc. is a clinical-stage biotechnology company. It engages in the business of developing oncolytic immunotherapies for the treatment of cancer. The company was founded by Philip Astley-Sparke, Colin A. Love, and Robert Coffin in March 2015 and is headquartered in Woburn, MA.

Replimune Group Inc

Replimune Group is trading with high volatility following a positive 10-3 advisory committee vote on the efficacy of its melanoma treatment, fueling investor speculation regarding a potential FDA approval by the upcoming deadline. The community remains deeply divided, with bulls anticipating a short squeeze and a path to approval, while bears express significant skepticism due to past regulatory rejections and concerns about the company's long-term cash runway and trial data quality.

XPeng, Inc. engages in the design, development, manufacture, and marketing of smart electric vehicles. Its products are environmentally friendly vehicles, namely an SUV (the G3) and a four-door sports sedan (the P7). It also provides a range of services to the clients, including supercharging service, maintenance service, ride-hailing service and vehicle leasing service. The company was founded by Xiao Peng He, Heng Xia, and Tao He in 2015 and is headquartered in Guangzhou, China.

XPeng Inc - ADR

XPeng is trending due to the company's aggressive push into physical AI, including upcoming mass production of humanoid robots and continued expansion of its autonomous driving technology. Investors are actively debating the stock's long-term valuation potential as a tech-focused AI platform versus its current pricing as a traditional automotive manufacturer, while community sentiment remains split between excitement over innovation and frustration with recent downward price pressure.

Hyperliquid is a layer one (L1) blockchain best known for perpetual futures and spot trading. Beyond its flagship DEX trading platform, the ecosystem supports borrowing, lending, real world assets (RWAs), and a full-fledged Ethereum Virtual Machine (EVM), making it a leading force in decentralized finance (defi).   Just as electronic trading dramatically improved markets in the 2000s, Hyperliquid offers an opportunity for a massive technical upgrade of the existing financial system through a transparent, efficient, and resilient blockchain. HYPE is the native token of the Hyperliquid blockchain, with a maximum supply of 1 billion.

Hype

HYPE is capturing significant market attention as traders react to the platform's unique fee-burning tokenomics and its expansion into real-world asset trading, including highly anticipated pre-IPO contracts. The community remains deeply divided between long-term bulls highlighting institutional adoption and protocol-driven buybacks, and skeptics emphasizing concerns over volatility, market structure, and broader crypto-sector headwinds.

Walmart, Inc. engages in the retail and wholesale business. The company offers an assortment of merchandise and services at everyday low prices. It operates through the following business segments: Walmart U.S., Walmart International, and Sam's Club. The Walmart U.S. segment operates as a mass merchandiser of consumer products, operating under the Walmart and Walmart Neighborhood Market brands, including walmart.com. The Walmart International segment includes operations of wholly-owned subsidiaries in Canada, Chile, China, and Africa, and majority-owned subsidiaries in India, as well as Mexico and Central America. The Sam's Club segment manages membership-only warehouse clubs and operates samsclub.com. The company was founded by Samuel Moore Walton and James Lawrence Walton on July 2, 1962 and is headquartered in Bentonville, AR.

Walmart Inc

Investors are actively debating Walmart's near-term outlook as technical indicators signal potential caution, with the community closely tracking whether the retailer can maintain margins while navigating competitive price-cutting strategies. Sentiment remains polarized between those viewing current pullbacks as a long-term buying opportunity and others concerned about sustained downward pressure in a challenging retail environment.

SPDR S&P 500 ETF TRUST - SPDR S&P 500 ETF Trust

Market sentiment remains highly volatile as investors weigh conflicting reports over potential Iran ceasefire negotiations against ongoing geopolitical tensions in the Strait of Hormuz. Despite these uncertainties, the index is trending upward on strong tech earnings and broader institutional buying, keeping the community divided between those aggressively chasing all-time highs and others bracing for a potential reversal.

Invesco DB US Dollar Index Bullish Fund - Invesco DB US Dollar Index Bullish Fund

Invesco DB US Dollar Index Bullish Fund

UUP is currently being driven by market uncertainty surrounding Fed policy shifts, heightened geopolitical tensions in the Middle East, and significant currency interventions by global central banks. The community is actively debating the dollar's role as a safe haven amid concerns over inflationary pressures and the potential impact of monetary tightening on global liquidity.

Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care and Rare Disease segments. The Diabetes and Obesity Care segment includes diabetes, obesity, cardiovascular, and emerging therapy areas. The Rare Disease segment refers to rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company was founded by Harald Pedersen and Thorvald Pedersen in 1923 is headquartered in Bagsværd, Denmark.

Novo Nordisk - ADR

Novo Nordisk A/S

Novo Nordisk is capturing investor attention as it expands its oral Wegovy pill availability globally and navigates a high-profile legal challenge against Eli Lilly regarding advertising claims. Community sentiment remains mixed, with bulls highlighting the pill's growth trajectory and strong fundamental position, while others express frustration over management and the stock's recent price consolidation.

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

ImmunityBio is trending as investors weigh strong international expansion in the Middle East against ongoing concerns regarding the company's clinical roadmap and the lack of a confirmed earnings date. The community remains divided, with long-term holders highlighting recent UAE approvals and the potential for a global partnership, while others focus on high cash burn and the volatility of its current valuation.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 
